| Literature DB >> 32533838 |
Baoyong Zhou1, Wei Zhao2, Ruixi Feng2, Xiaohui Zhang3, Xuemei Li4, Yang Zhou4, Li Peng4, Yixin Li4, Jinyan Zhang4, Jing Luo4, Lingyu Li4, Jingxian Wu4, Changhong Yang2, Meijiao Wang2, Yong Zhao4, Kejian Wang2, Huarong Yu2, Qiling Peng2, Ning Jiang4.
Abstract
The coronavirus disease 2019 (COVID-2019) that emerged in Wuhan, China, has rapidly spread to many countries across all six WHO regions. However, its pathobiology remains incompletely understood and many efforts are underway to study it worldwide. To clarify its pathogenesis to some extent, it will inevitably require lots of COVID-2019-associated pathological autopsies. Pathologists from all over the world have raised concerns with pathological autopsy relating to COVID-2019. The issue of whether a person died from COVID-2019 infection or not is always an ambiguous problem in some cases, and ongoing epidemiology from China may shed light on it. This review retrospectively summarizes the research status of pathological autopsy for COVID-2019 deaths in China, which will be important for the cause of death, prevention, control and clinical strategies of COVID-2019. Moreover, it points out several challenges at autopsy. We believe pathological studies from China enable to correlate clinical symptoms and pathological features of COVID-2019 for doctors and provide an insight into COVID-2019 disease. © FEMS 2020.Entities:
Keywords: COVID-2019; infectious disease; pathological autopsy; pneumonia
Mesh：
Year: 2020 PMID： 32533838 PMCID： PMC7314003 DOI： 10.1093/femspd/ftaa026
Source DB: PubMed Journal: Pathog Dis ISSN： 2049-632X Impact factor: 3.166